TIVDAKT — 2162380
Application number
2162380
Registration number
TMA1237065
International Registration Number
1640981
Type(s)
Standard Characters
Category
Trademark
CIPO Status
CANCELLED
TM5 status
DEAD/REGISTRATION/
Surrendered
The trademark application was registered, but subsequently voluntarily removed from the registry by action of the owner.
Filed
2021-10-25
International Registration
2021-10-25
Registered Owner
Seagen Inc.
21823 30th Drive S.E.
Bothell WA 98021
UNITED STATES OF AMERICA
Agent
GOWLING WLG (CANADA) LLP
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
TORONTO
ONTARIO M5X1G5
Documents
Index headings
- TIVDAKT
- TIV DAKT
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of nervous system diseases, for the regulation of the immune system and for treatment of auto-immune diseases, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of cancer, and inflammatory disorders, for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
Services (Nice class & Statement)
- 42
- (1) Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
Claims
- Priority Filing Date: April 27, 2021, Country or Office: UNITED STATES OF AMERICA, Application No. 90675414 in association with the same kind of goods and in association with the same kind of services
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2021-10-25 | Registration | |
| International Registration | 2021-10-25 | 2031-10-25 | |
| Created | 2022-01-26 | ||
| Formalized | 2022-01-26 | ||
| Designation Notification - Madrid Protocol | 2022-01-27 | 2023-07-27 | |
| Notification of Possible Opposition Sent | 2022-11-28 | ||
| Search Recorded | 2023-03-10 | ||
| Examiner's First Report | 2023-03-10 | 2023-09-10 | |
| Total Provisional Refusal | 2023-03-10 | 2023-09-10 | |
| Agent Changed | 2023-03-16 | From/De: To/A: 32 | |
| Approved | 2024-02-23 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2024-02-23 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2024-03-20 | Vol.71 Issue 3621 | |
| Opposition Start Date Notice Sent | 2024-03-20 | Requested on 2024/03/20 00:30:12 in program jr500m1 | |
| Registration Pending | 2024-06-07 | ||
| Registered | 2024-06-07 | ||
| Statement of Grant of Protection Sent (following a Provisional Refusal) | 2024-06-07 | ||
| Cancelled - Madrid Protocol | 2024-11-20 | Effective Date: 2024-10-31 |